Celltrion is a leading global biopharmaceutical company that researches, develops,and manufactures antibody biosimilars and new biologics.Since our foundation, we have provided advanced and affordable treatment options for patients for a wide area of diseases, including autoimmune disease. Our launch of the world’s first antibody biosimilar product presented a new paradigm to the global biologics market, and the responsive and efficient development of COVID-19 therapeutics during the current global pandemic has helped people to return back to their everyday lives in full wellness. We will continue to grow as a global biopharmaceutical company based on our know-how in biotherapeutics and driven business strategy.